А.н. Militovska
А.н. Militovska has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Nataliya Oleksandrivna Nekrasova
Харківський національний медичний університет
2 shared publications - Ye. T. Soloviova
Kharkiv National Medical University of the Ministry of Health of Ukraine, Kharkiv, Ukraine
2 shared publications - A.V. Stromylo
Kharkiv National Medical University of the Ministry of Health of Ukraine, Kharkiv, Ukraine
1 shared publication - I. I. Chernenko
V.N. Karazin Kharkiv National University of the Ministry of Education and Science of Ukraine, Kharkiv, Ukraine
1 shared publication - I.V. Darii
Kharkiv National Medical University of the Ministry of Health of Ukraine, Kharkiv, Ukraine
1 shared publication - Oksana I. Kauk
Kharkiv National Medical University, Kharkiv, Ukraine
1 shared publication
Latest Publications
- Open Access
- 30 June 2026
- Published by V. N. Karazin Kharkiv National University in Psychiatry, Neurology and Medical Psychology
- Vol. 13 (3(35)) , 418-432
The use of memantine for the correction of cognitive impairment in people who have suffered ischemic stroke: results of clinical observation and literature review
Background. Post-stroke cognitive impairment is a common complication of ischemic stroke with an unfavorable long-term prognosis associated with decreased functional independence and an increased risk of recurrent vascular events. Despite the established role of glutamate-mediated excitotoxicity in the formation of cognitive deficits in ischemic stroke, clinical data on the use of NMDA receptor antagonists directly in the post-stroke population remain limited. Purpose – to assess the dynamics of cognitive and functional status in patients with post-stroke cognitive impairment during 9 months of memantine therapy, as well as to conduct a critical analysis of the current literature on the pathogenesis of post-stroke cognitive impairment and clinical data on the use of memantine in vascular cognitive pathology. Materials and methods. The clinical part included 60 patients with cognitive impairment after stroke (MMSE ≤ 25 points): the main group received memantine (titration 5→20 mg/day) as part of standard therapy (n = 30), the control group received only standard therapy (n = 30). The duration of observation was 9 months; control points: 0, 3, 6, 9 months. Statistical analysis: Shapiro–Wilk test, Wilcoxon test for dependent samples, Mann–Whitney test, Cohen’s coefficient (p < 0.05). A narrative review of the literature was conducted using the MEDLINE/PubMed and Scopus databases (2021–2026; keywords: cognitive impairment after stroke, memantine, NMDA receptor, vascular cognitive impairment). Results. The groups were comparable in terms of baseline characteristics (p > 0.05). In the main group, statistically significant positive dynamics of MMSE were found at all control points: at the 9th month Δ = +2.7 points (p = 0.001; Cohen’s d = 0.74). The dynamics of the Barthel index were also significant with an increasing effect: at the 9th month Δ = +10.8 points (p < 0.001; Cohen’s d = 0.97). In the control group, statistically significant changes in MMSE and Barthel index were not recorded (p = 0.087–0.143). Between-group differences at the 9th month: MMSE +1.1 points (p = 0.041), Barthel +6.1 points (p = 0.028). Subgroup analysis revealed a statistically significant improvement in patients with mild and moderate cognitive impairment (MCI); in the severe PD subgroup, the effect did not reach statistical significance (p > 0.05). Conclusions. The addition of memantine to standard therapy was associated with modest improvements in cognitive and functional status at 9 months of follow-up, mainly in patients with mild to moderate cognitive impairment. The results obtained in our study need to be confirmed in larger randomized trials.
- 30 June 2026
- Published by V. N. Karazin Kharkiv National University in Psychiatry, Neurology and Medical Psychology
- Vol. 13 (3(35)) , 418-432
Open AccessThe use of memantine for the correction of cognitive impairment in people who have suffered ischemic stroke: results of clinical observation and literature review
Background. Post-stroke cognitive impairment is a common complication of ischemic stroke with an unfavorable long-term prognosis associated with decreased functional independence and an increased risk of recurrent vascular events. Despite the established role of glutamate-mediated excitotoxicity in the formation of cognitive deficits in ischemic stroke, clinical data on the use of NMDA receptor antagonists directly in the post-stroke population remain limited. Purpose – to assess the dynamics of cognitive and functional status in patients with post-stroke cognitive impairment during 9 months of memantine therapy, as well as to conduct a critical analysis of the current literature on the pathogenesis of post-stroke cognitive impairment and clinical data on the use of memantine in vascular cognitive pathology. Materials and methods. The clinical part included 60 patients with cognitive impairment after stroke (MMSE ≤ 25 points): the main group received memantine (titration 5→20 mg/day) as part of standard therapy (n = 30), the control group received only standard therapy (n = 30). The duration of observation was 9 months; control points: 0, 3, 6, 9 months. Statistical analysis: Shapiro–Wilk test, Wilcoxon test for dependent samples, Mann–Whitney test, Cohen’s coefficient (p < 0.05). A narrative review of the literature was conducted using the MEDLINE/PubMed and Scopus databases (2021–2026; keywords: cognitive impairment after stroke, memantine, NMDA receptor, vascular cognitive impairment). Results. The groups were comparable in terms of baseline characteristics (p > 0.05). In the main group, statistically significant positive dynamics of MMSE were found at all control points: at the 9th month Δ = +2.7 points (p = 0.001; Cohen’s d = 0.74). The dynamics of the Barthel index were also significant with an increasing effect: at the 9th month Δ = +10.8 points (p < 0.001; Cohen’s d = 0.97). In the control group, statistically significant changes in MMSE and Barthel index were not recorded (p = 0.087–0.143). Between-group differences at the 9th month: MMSE +1.1 points (p = 0.041), Barthel +6.1 points (p = 0.028). Subgroup analysis revealed a statistically significant improvement in patients with mild and moderate cognitive impairment (MCI); in the severe PD subgroup, the effect did not reach statistical significance (p > 0.05). Conclusions. The addition of memantine to standard therapy was associated with modest improvements in cognitive and functional status at 9 months of follow-up, mainly in patients with mild to moderate cognitive impairment. The results obtained in our study need to be confirmed in larger randomized trials.
- 31 October 2025
- Published by V. N. Karazin Kharkiv National University in Psychiatry, Neurology and Medical Psychology
- No. 31,p. 700-709
Relevant problems of differential diagnostics of myelitis (by a clinical example)
Background. Infammation of the central nervous system (CNS) takes a special place among all the neurological diseases. Myelitis serves an example of such an infammation, remaining in the spotlight of scientifc research. First, as locally isolated form of lesion, it occurs fairly rarely, therefore the obstacles in systematizing the data about its etiology, pathogenesis, classifcation, clinical features, etc. Second, making the fnal diagnosis may be challenging, since there are many autoimmune, demyelinating, and other diseases, which could result into the spinal cord infam mation. Moreover, the rational way of examining such patients is also unclear – the question is whether itʼs realistic to fnd out the exact reason of myelitis in every single case, or itʼs acceptable to postulate «idiopathic» forms. Altogether, after taking into consideration the presence of controversial information, it would be reasonable to perform a literature review and to present a clinical case in this article. Purpose – the purpose of this work is to compile the relevant data about trans verse myelitis and illustrate it with a clinical example. Materials and Methods. The literature resources dedicated to transverse myelitis and the patientʼs medical documentation were analyzed. Results. The patientʼs anamnesis and the results of his laboratory and instrumental tests indicated the presence of transverse myelitis, accompanied with paraplegia,hypoesthesia beneath the Th8-9 level, and the central type of pelvic organ dysfunction. Anti-infammatory and immunoglobulin therapy resulted in a positive outcome:partial recovery of motor function in the lower limbs (up to 2–3 points on the MRC scale), decreased sensory defcit, and partial restoration of bladder control. Conclusions. Transverse myelitis as an isolated form of the CNS lesion is a challenge for neurological practice. The main difculties are associated with the necessity of making the diagnosis by method of exclusion, implying performing numerous high-priced tests which may not justify the means wasted on diagnostics. The future of such patients is also indefnite. According to the most pessimistic assessments, up to two third of cases remain without an identifed reason of myelitis, and up to one third of the examinees have severe neurological defcit after this disease, resulting into permanent disability. In this case the outcome was a favorable recovery trend was observed: partial motor improvement, reduced sensory impairment, and better bladder control.
- 31 October 2025
- Published by V. N. Karazin Kharkiv National University in Psychiatry, Neurology and Medical Psychology
- No. 31,p. 700-709
Relevant problems of differential diagnostics of myelitis (by a clinical example)
Background. Infammation of the central nervous system (CNS) takes a special place among all the neurological diseases. Myelitis serves an example of such an infammation, remaining in the spotlight of scientifc research. First, as locally isolated form of lesion, it occurs fairly rarely, therefore the obstacles in systematizing the data about its etiology, pathogenesis, classifcation, clinical features, etc. Second, making the fnal diagnosis may be challenging, since there are many autoimmune, demyelinating, and other diseases, which could result into the spinal cord infam mation. Moreover, the rational way of examining such patients is also unclear – the question is whether itʼs realistic to fnd out the exact reason of myelitis in every single case, or itʼs acceptable to postulate «idiopathic» forms. Altogether, after taking into consideration the presence of controversial information, it would be reasonable to perform a literature review and to present a clinical case in this article. Purpose – the purpose of this work is to compile the relevant data about trans verse myelitis and illustrate it with a clinical example. Materials and Methods. The literature resources dedicated to transverse myelitis and the patientʼs medical documentation were analyzed. Results. The patientʼs anamnesis and the results of his laboratory and instrumental tests indicated the presence of transverse myelitis, accompanied with paraplegia,hypoesthesia beneath the Th8-9 level, and the central type of pelvic organ dysfunction. Anti-infammatory and immunoglobulin therapy resulted in a positive outcome:partial recovery of motor function in the lower limbs (up to 2–3 points on the MRC scale), decreased sensory defcit, and partial restoration of bladder control. Conclusions. Transverse myelitis as an isolated form of the CNS lesion is a challenge for neurological practice. The main difculties are associated with the necessity of making the diagnosis by method of exclusion, implying performing numerous high-priced tests which may not justify the means wasted on diagnostics. The future of such patients is also indefnite. According to the most pessimistic assessments, up to two third of cases remain without an identifed reason of myelitis, and up to one third of the examinees have severe neurological defcit after this disease, resulting into permanent disability. In this case the outcome was a favorable recovery trend was observed: partial motor improvement, reduced sensory impairment, and better bladder control.